These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 17182674)
1. The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production. Bouamr F; Houck-Loomis BR; De Los Santos M; Casaday RJ; Johnson MC; Goff SP J Virol; 2007 Mar; 81(6):2909-22. PubMed ID: 17182674 [TBL] [Abstract][Full Text] [Related]
2. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. Pornillos O; Higginson DS; Stray KM; Fisher RD; Garrus JE; Payne M; He GP; Wang HE; Morham SG; Sundquist WI J Cell Biol; 2003 Aug; 162(3):425-34. PubMed ID: 12900394 [TBL] [Abstract][Full Text] [Related]
3. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release. Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Martin-Serrano J; Zang T; Bieniasz PD Nat Med; 2001 Dec; 7(12):1313-9. PubMed ID: 11726971 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Demirov DG; Ono A; Orenstein JM; Freed EO Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336 [TBL] [Abstract][Full Text] [Related]
7. Identification of human VPS37C, a component of endosomal sorting complex required for transport-I important for viral budding. Eastman SW; Martin-Serrano J; Chung W; Zang T; Bieniasz PD J Biol Chem; 2005 Jan; 280(1):628-36. PubMed ID: 15509564 [TBL] [Abstract][Full Text] [Related]
8. The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. Stuchell MD; Garrus JE; Müller B; Stray KM; Ghaffarian S; McKinnon R; Kräusslich HG; Morham SG; Sundquist WI J Biol Chem; 2004 Aug; 279(34):36059-71. PubMed ID: 15218037 [TBL] [Abstract][Full Text] [Related]
9. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Medina G; Zhang Y; Tang Y; Gottwein E; Vana ML; Bouamr F; Leis J; Carter CA Traffic; 2005 Oct; 6(10):880-94. PubMed ID: 16138902 [TBL] [Abstract][Full Text] [Related]
10. Tsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag. Myers EL; Allen JF J Virol; 2002 Nov; 76(22):11226-35. PubMed ID: 12388682 [TBL] [Abstract][Full Text] [Related]
11. Role of ESCRT-I in retroviral budding. Martin-Serrano J; Zang T; Bieniasz PD J Virol; 2003 Apr; 77(8):4794-804. PubMed ID: 12663786 [TBL] [Abstract][Full Text] [Related]
12. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures. Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271 [TBL] [Abstract][Full Text] [Related]
13. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. Goff A; Ehrlich LS; Cohen SN; Carter CA J Virol; 2003 Sep; 77(17):9173-82. PubMed ID: 12915533 [TBL] [Abstract][Full Text] [Related]
14. Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. Dussupt V; Sette P; Bello NF; Javid MP; Nagashima K; Bouamr F J Virol; 2011 Mar; 85(5):2304-15. PubMed ID: 21159863 [TBL] [Abstract][Full Text] [Related]